Improving Symptoms in Patients with HFrEF Using Novel Device Therapy

Published: Aug. 7, 2023, 4 a.m.

Host: Nirav Y. Raval, MD, FACC
\n\n Guest: Gurusher Panjrath, MD, FACC, FAHA, FHFSA
\n\n\n \n

Despite the use of guideline-directed medical therapy, many patients with heart failure continue to have worsening symptoms. Enter baroreflex activation therapy, or BAT, an implantable FDA-approved cardiac autonomic modulation device. Listen in as Drs. Nirav Raval and Gurusher Panjrath explore data on its positive effects on exercise capacity, functional status, and quality of life. Do you know which of your patients may benefit from BAT?